These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27721405)

  • 1. EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.
    Ai J; Pascal LE; Wei L; Zang Y; Zhou Y; Yu X; Gong Y; Nakajima S; Nelson JB; Levine AS; Lan L; Wang Z
    Oncogene; 2017 Apr; 36(15):2054-2065. PubMed ID: 27721405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.
    Zang Y; Pascal LE; Zhou Y; Qiu X; Wei L; Ai J; Nelson JB; Zhong M; Xue B; Wang S; Yang D; Lan L; Shan Y; Wang Z
    Cancer Lett; 2018 Feb; 415():198-207. PubMed ID: 29179998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
    Pascal LE; Su F; Wang D; Ai J; Song Q; Wang Y; O'Malley KJ; Cross B; Rigatti LH; Green A; Dhir R; Wang Z
    Neoplasia; 2019 Aug; 21(8):752-764. PubMed ID: 31229879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
    Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.
    Pascal LE; Wang Y; Zhong M; Wang D; Chakka AB; Yang Z; Li F; Song Q; Rigatti LH; Chaparala S; Chandran U; Parwani AV; Wang Z
    Neoplasia; 2018 Apr; 20(4):351-363. PubMed ID: 29518696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.
    Yang T; Jing Y; Dong J; Yu X; Zhong M; Pascal LE; Wang D; Zhang Z; Qiao B; Wang Z
    Prostate; 2018 Nov; 78(15):1201-1212. PubMed ID: 30009504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.
    Wang Y; Pascal LE; Zhong M; Ai J; Wang D; Jing Y; Pilch J; Song Q; Rigatti LH; Graham LE; Nelson JB; Parwani AV; Wang Z
    Endocrinology; 2017 Dec; 158(12):4189-4205. PubMed ID: 29029019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
    Cai L; Wang D; Fisher AL; Wang Z
    Biochem Biophys Res Commun; 2014 May; 447(2):292-8. PubMed ID: 24727455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
    Xiao W; Zhang Q; Habermacher G; Yang X; Zhang AY; Cai X; Hahn J; Liu J; Pins M; Doglio L; Dhir R; Gingrich J; Wang Z
    Oncogene; 2008 Mar; 27(11):1536-44. PubMed ID: 17873910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway.
    Lyu F; Huang S; Yan Z; He Q; Liu C; Cheng L; Cong Y; Chen K; Song Y; Xing Y
    Cell Signal; 2024 Jul; 119():111164. PubMed ID: 38583745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, localization and focus formation at DNA damage sites of canine Ku70.
    Koike M; Yutoku Y; Koike A
    J Vet Med Sci; 2017 Mar; 79(3):554-561. PubMed ID: 28163277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.
    Xiao W; Jiang F; Wang Z
    Prostate; 2006 Jan; 66(1):1-12. PubMed ID: 16114057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
    Hahn J; Xiao W; Jiang F; Simone F; Thirman MJ; Wang Z
    Prostate; 2007 Feb; 67(2):146-53. PubMed ID: 17044034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Castration therapy results in decreased Ku70 levels in prostate cancer.
    Al-Ubaidi FL; Schultz N; Loseva O; Egevad L; Granfors T; Helleday T
    Clin Cancer Res; 2013 Mar; 19(6):1547-56. PubMed ID: 23349316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear localization of mouse Ku70 in interphase cells and focus formation of mouse Ku70 at DNA damage sites immediately after irradiation.
    Koike M; Yutoku Y; Koike A
    J Vet Med Sci; 2015 Sep; 77(9):1137-42. PubMed ID: 25947323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
    Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
    Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer.
    Lv S; Wu Z; Luo M; Zhang Y; Zhang J; Pascal LE; Wang Z; Wei Q
    Cell Death Dis; 2022 Sep; 13(9):754. PubMed ID: 36050295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
    Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
    Oncotarget; 2016 May; 7(20):29245-54. PubMed ID: 27058417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair.
    Hsu JL; Leong PK; Ho YF; Hsu LC; Lu PH; Chen CS; Guh JH
    Cancer Lett; 2012 Jun; 319(2):214-222. PubMed ID: 22261337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
    Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
    Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.